HIV-1 Protease Activity Assay Kit (Fluorometric)
Catalog number
K825-100
Name
HIV-1 Protease Activity Assay Kit (Fluorometric)
Size
100 assays
Price
540.00 EUR
Supplier
Details
Kit's description
Human Immunodeficiency Virus (HIV) is the cause of the Acquired Immunodeficiency Syndrome (AIDS). HIV-1 protease is a retroviral aspartyl protease (retropepsin) that is essential for the life-cycle of the virus as it cleaves newly synthesized polyproteins at the appropriate places to create the mature protein components of an infectious HIV virion. Without effective HIV1 protease, HIV virions remain non-infectious. BioVision’s HIV-1 Activity assay kit utilizes the ability of active HIV-1 protease to cleave a synthetic peptide substrate to release the free fluorophore which can be easily quantified (Ex/Em = 330/450 nm) using a fluorometer or fluorescence microplate reader. This assay kit is simple, rapid and can detect HIV-1 protease activity in samples and of purified enzyme.
Highlights
Sensitive fluorometric assay to detect HIV:1 Protease activity.
Kit's benefits
Simple, sensitive assay. Fluorometric detection
Category
Protease activity
Kit's other name
HIV-1 Retropepsin activity assay kit, cd05482 activity assay kit
Contents
HIV-1 Protease Assay Buffer HIV-1 Protease Dilution Buffer HIV-1 Protease Substrate HIV-1 Protease (Positive Control) Fl. Standard (10 mM in DMSO)
Storage condition
-80°C
Shipping condition
dry ice
Maximum time can be stored
12 months
Species reactivity
Sensitive fluorometric assay to detect HIV:1 Protease activity.
Applications
• Detect activity of recombinant HIV-1 protease • Determine activity of purified HIV-1 protease
Samples tested
Proteins/lysates
Virus
hiv
Test
Biovision supplies other types of Assays as 1.
Gene
The human immunodeficiency virus (HIV) is a lentivirus (a subgroup of retrovirus) that causes HIV infection and over time acquired immunodeficiency syndrome(AIDS). AIDS is a condition in humans in which progressive failure of the immune system allows life-threatening opportunistic infections and cancers to thrive. Without treatment, average survival time after infection with HIV is estimated to be 9 to 11 years, depending on the HIV subtype. Infection with HIV occurs by the transfer of blood, semen, vaginal fluid, pre-ejaculate, or breast milk. Within these bodily fluids, HIV is present as both free virus particles and virus within infected immune cells. recombinant HIV 1 and 2 gag gene proteins p24, p17, p55 immunodominant epitopes and envelope glycoproteins, gp120 are used for production of diagnostic detection antibodies.